TipRanks
Satellos Bioscience (DE:0IT)
FRANKFURT:0IT
Germany Market
0IT
Satellos Bioscience
RESEARCH TOOLSreports

Satellos Bioscience (0IT) Stock News & Sentiment

0 Followers
Analyst Reiterates Buy on Satellos Bioscience, Maintains Unchanged $22 Price Target Amid Steady DMD Trial Progress
Premium
Ratings
Analyst Reiterates Buy on Satellos Bioscience, Maintains Unchanged $22 Price Target Amid Steady DMD Trial Progress
10h ago
MSLE
Satellos Completes Enrollment in BASECAMP Phase 2 Trial of Forazapadin for Duchenne Muscular Dystrophy
Premium
Company Announcements
Satellos Completes Enrollment in BASECAMP Phase 2 Trial of Forazapadin for Duchenne Muscular Dystrophy
23h ago
6K
MSLE
Satellos Bioscience: Regulatory Advances and Upcoming DMD Readouts Support Buy Rating, Price Target Maintained at $22
Premium
Ratings
Satellos Bioscience: Regulatory Advances and Upcoming DMD Readouts Support Buy Rating, Price Target Maintained at $22
7d ago
MSLE
Satellos Wins FDA Green Light for FSHD Trial and Secures Up to US$5 Million in Non-Dilutive Funding
Premium
Company Announcements
Satellos Wins FDA Green Light for FSHD Trial and Secures Up to US$5 Million in Non-Dilutive Funding
7d ago
MSLE
Satellos Bioscience to Showcase Forazapadin Program at World Muscle Society Congress
Premium
Company Announcements
Satellos Bioscience to Showcase Forazapadin Program at World Muscle Society Congress
16d ago
6K
MSLE
Satellos Bioscience Secures INN ‘Forazapadin’ for Lead Duchenne Drug as Phase 2 Programs Advance
Premium
Company Announcements
Satellos Bioscience Secures INN ‘Forazapadin’ for Lead Duchenne Drug as Phase 2 Programs Advance
22d ago
6K
MSLE
Satellos Bioscience to Showcase DMD Drug Program at September Investor Conferences
Premium
Company Announcements
Satellos Bioscience to Showcase DMD Drug Program at September Investor Conferences
30d ago
6K
MSLE
More DE:0IT News >

0IT News on the Web

Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Kyverna Therapeutics, Inc. (KYTX)
TipRanks News
Bullish
Satellos Bioscience to Showcase DMD Drug Program at September Investor Conferences
TipRanks News
Neutral
LifeSci Capital Sticks to Their Buy Rating for Satellos Bioscience (MSLE)
TipRanks News
Bullish
Satellos Bioscience Sets Up US$50 Million U.S. At-the-Market Share Sales Facility
TipRanks News
Neutral
Top Biotech Gainers: ZCMD Surges 190%, LABT Advances On Nu-3 Progress, ARWR Hits The Targets
rttnews
Bullish
Satellos Bioscience Posts Encouraging Six-Month TRAILHEAD Data in Adult DMD Patients
TipRanks News
Neutral
Guggenheim Keeps Their Buy Rating on Satellos Bioscience (MSLE)
TipRanks News
Bullish
Satellos' SAT-3247 Wins FDA Fast Track Status For Duchenne Muscular Dystrophy, Stock Up
rttnews
Bullish

News Score - Last 7 Days

Very Positive
DE:0IT
Sector Average
Media Buzz
This Week5 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:0IT’s Media Buzz Sentiment?
5 articles about DE:0IT were published this week. In an average week, 2 articles are published.
    What is DE:0IT’s weekly average amount of articles?
    In an average week, 2 articles about DE:0IT are published.
      What is DE:0IT’s News Sentiment?
      100% of articles about DE:0IT were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SMMTSummit Therapeutics
        CDNACareDx
        ARGXArgenx Se
        MEOBFMesoblast Limited
        KODKodiak Sciences
        Showing the stocks with the most bullish news sentiment over the past week